Which pathogens predominate in acute chest syndrome among sickle cell disease patients?

Which pathogens predominate in acute chest syndrome among sickle cell disease patients?

• A. Mycoplasma and Chlamydophila
• B. Streptococcus pneumoniae only
• C. Pseudomonas aeruginosa
• D. Escherichia coli

Answer: (A)

In acute chest syndrome for patients with sickle cell disease, infection often triggers the event, and atypical respiratory pathogens are frequently implicated. Mycoplasma pneumoniae and Chlamydophila (Chlamydia) pneumoniae are common culprits because they tend to cause interstitial or atypical pneumonia with diffuse infiltrates, which aligns with the chest imaging seen in ACS. These organisms lack a typical cell wall (Mycoplasma) or live intracellularly (Chlamydophila), so they aren’t always detected on standard Gram stains or routine cultures and require targeted testing such as PCR or serology. Because of this pattern, empiric treatment for ACS commonly includes agents active against atypical pathogens (for example, macrolides or doxycycline) in addition to coverage for typical bacteria. While other bacteria like Streptococcus pneumoniae can contribute to ACS, the question reflects the clinical emphasis on atypical pathogens being predominant in this scenario.

In acute chest syndrome for patients with sickle cell disease, infection often triggers the event, and atypical respiratory pathogens are frequently implicated. Mycoplasma pneumoniae and Chlamydophila (Chlamydia) pneumoniae are common culprits because they tend to cause interstitial or atypical pneumonia with diffuse infiltrates, which aligns with the chest imaging seen in ACS. These organisms lack a typical cell wall (Mycoplasma) or live intracellularly (Chlamydophila), so they aren’t always detected on standard Gram stains or routine cultures and require targeted testing such as PCR or serology. Because of this pattern, empiric treatment for ACS commonly includes agents active against atypical pathogens (for example, macrolides or doxycycline) in addition to coverage for typical bacteria. While other bacteria like Streptococcus pneumoniae can contribute to ACS, the question reflects the clinical emphasis on atypical pathogens being predominant in this scenario.